When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Sienna Biopharmaceuticals (SNNA+2.6%) announces results from a first-in-human study of JAK3/TrkA inhibitor SNA-125 for the topical treatment of mild-to-moderate psoriasis.
More news on: Sienna Biopharmaceuticals, Healthcare stocks news, Stocks on the move,